Wim M. Vos

Favorable outcome in clinically stage II melanoma patients is associated with the presence of activated tumor infiltrating T‐lymphocytes and preserved MHC class I antigen expression

Erik Hooijberg, T. D. de Gruijl, P. V. van Leeuwen, 2008, International journal of cancer.